Lippman Evan has filed 9 insider transactions across 1 company since May 2025.
Most recent transaction: a option exercise of 74008 shares of TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA) on May 14, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Lippman Evan | EVP, Business Development | M | Restricted Share Units | 74008 | $0.00 | 74,008.0000 | 1,179,000,000 | 50.00% | 0.01% |
| May 14, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Lippman Evan | EVP, Business Development | M | Ordinary Shares | 74008 | $0.00 | 80,103.0000 | 1,179,000,000 | 1214.24% | 0.01% |
| May 14, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Lippman Evan | EVP, Business Development | S | Ordinary Shares | 35912 | $35.58 | 44,191.0000 | 1,179,000,000 | 44.83% | 0.00% |
| May 14, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Lippman Evan | EVP, Business Development | M | Restricted Share Units | 11841 | $0.00 | 35,524.0000 | 1,179,000,000 | 25.00% | 0.00% |
| May 14, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Lippman Evan | EVP, Business Development | M | Ordinary Shares | 11841 | $0.00 | 11,841.0000 | 1,179,000,000 | 9999.99% | 0.00% |
| May 14, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Lippman Evan | EVP, Business Development | S | Ordinary Shares | 5746 | $35.58 | 6,095.0000 | 1,179,000,000 | 48.53% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Lippman Evan | EVP, Business Development | A | Restricted Share Units | 27347 | $0.00 | 27,347.0000 | 1,163,000,000 | 9999.99% | 0.00% |
| May 14, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Lippman Evan | EVP, Business Development | A | Restricted Share Units | 148016 | $0.00 | 148,016.0000 | 1,159,000,000 | 9999.99% | 0.01% |
| May 14, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Lippman Evan | EVP, Business Development | A | Restricted Share Units | 47365 | $0.00 | 47,365.0000 | 1,159,000,000 | 9999.99% | 0.00% |